12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ozurdex dexamethasone intravitreal implant regulatory update

The Scottish Medicines Consortium recommended against the use of Ozurdex dexamethasone intravitreal implant on the National Health Service (NHS) in Scotland to treat non-infectious uveitis affecting the posterior segment of the eye in adults...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >